Science
Revolutionizing delivery
across the blood-brain barrier.
Our Platform: TRACER
Reaching CNS targets once thought unreachable.
Voyager’s TRACER™ (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) capsid discovery platform is a broadly applicable, RNA-based screening platform that enables rapid discovery of AAV capsids with robust penetration of the blood-brain barrier and enhanced central nervous system (CNS) tropism in multiple species, including non-human primates (NHPs).
Non-Viral Approaches
Multiple modalities to treat neurological diseases.
“I love how we all get to collaborate, even though we are on different teams.”
![Voyager_publications_img](https://www.voyagertherapeutics.com/wp-content/uploads/2023/12/Voyager_publications_img.jpg)
Recent Publications & Presentations
ASGCT 2024: Friday, May 10th
Our Pipeline
Partnerships
Our allies in realizing the potential of neuro-genetic medicines
![Partner_Logo_White_Alexion](https://www.voyagertherapeutics.com/wp-content/uploads/2023/12/Partner_Logo_White_Alexion.png)
![Partner_Logo_White_Neurocrine](https://www.voyagertherapeutics.com/wp-content/uploads/2023/12/Partner_Logo_White_Neurocrine.png)
![Partner_Logo_White_Novartis](https://www.voyagertherapeutics.com/wp-content/uploads/2023/12/Partner_Logo_White_Novartis.png)
![Partner_Logo_White_Sangamo](https://www.voyagertherapeutics.com/wp-content/uploads/2023/12/Partner_Logo_White_Sangamo.png)